Surveillance in Lynch syndrome

Familial Cancer

Volumn 4, Issue 3, 2005, Pages 267-271

  Mecklin, Jukka Pekka ^a   Järvinen, Heikki J ^b  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

High risk for colorectal cancer; HNPCC and surveillance; Prevention of colorectal cancer

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOMA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; COST EFFECTIVENESS ANALYSIS; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE GENITAL TRACT TUMOR; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HEALTH BEHAVIOR; HUMAN; LARGE INTESTINE TUMOR; MISMATCH REPAIR; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; TRANSVAGINAL ECHOGRAPHY;

COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; MASS SCREENING;

EID: 24144488736     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-005-1475-x     Document Type: Review

References (40)

1. J Wijnen PM Khan H Vasen 1997 Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mistmatch-repair-gene mutations Am J Human Genet 61 329 35
2. E Renkonen Y Zhang H Lohi 2003 Altered expression of MLH1, MSH2 and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer J Clin Oncol 21 3629 37
3. G Lerman C Hughes B Trock 1999 Genetic testing in families with hereditary nonpolyposis colon cancer JAMA 281 1618 22
4. M Ponz de Leon P Benatti Di Gregorio 2004 Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer Br J Cancer 23 882 7
5. K Aktan-Collan J-P Mecklin HJ Järvinen 2000 Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction Int J Cancer 89 44 50
6. W Burke G Petersen P Lynch 1997 Recommendations for follow-up care of individuals with an inherited predisposition to cancer JAMA 11 915 9
7. H Järvinen M Aarnio H Mustonen 2000 Controlled 15-year trial on screening for colorectal cancer families with hereditary nonpolyposis colorectal cancer Gastroenterology 118 829 34
8. HF Vasen J-P Mecklin PM Khan HT Lynch 1991 The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC) Dis Colon Rectum 34 424 5
9. HF Vasen FM Nagengast PM Khan 1995 Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) Lancet 345 1183 4
10. HT Lynch A de la Chapelle 2003 Hereditary colorectal cancer N Engl J Med 348 919 32
11. G Möslein S Pistorius H-D Saeger HK Schackert 2003 Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome Langenbecks Arch Surg 388 9 16
12. M Aarnio R Sankila E Pukkala 1999 Cancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 214 218
13. J Wijnen W de Leeuw H Vasen 1999 Familial endometrial cancer in female carriers of MSH6 germline mutations Nat Genet 2 142 4
14. M Aarnio J-P Mecklin LA Aaltonen 1995 Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome Int J Cancer 64 430 3
15. A Wagner Y Hendriks EJ Meijers-Heijboer 2001 Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutsch pedigree J Med Genet 38 318 22
16. HF Vasen 2000 Clinical diagnosis and management of hereditary colorectal cancer syndromes J Clin Oncol 18 21 Suppl 81S 92S
17. HFA Vasen P Watson J-P Mecklin 1994 The epidemiology of endometrial cancer in heredtary nonpolyposis colorectal cancer Anticancer Res 14 1675 8
18. D Boks AP Trujillo AC Voogd 2002 Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer Int J Cancer 102 198 200
19. I Dove-Edwin B Dominique S Goff 2002 The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma Cancer 94 1708 12
20. J Church C Simmang 2003 Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer) Dis Colon Rectum 8 1001 12
21. J-P Mecklin HJ Järvinen 1991 Tumor spectrum in cancer family syndrome (Hereditary nonpolyposis colorectal cancer) Cancer 68 1109 12
22. SR Hamilton B Liu E Ramon 1995 The molecular basis of Turcot's syndrome N Engl J Med 332 839 47
23. HFA Vasen EACM Sanders BG Taal 1996 The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC) Int J Cancer 65 422 5
24. Barana D, van der Klift H, Wijnen J et al. Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC. Am J Med Genet 2004; 125: 318-9
25. K Hirano K Yamashita N Yamashita 2002 Non-Hodgkin's lymphoma in a patient with probable hereditary nonpolyposis colon cancer Dis Colon Rectum 45 273 9
26. C Soravia H van der Klift M-A Bründler 2003 Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum Am J of Med Genet 121A 159 62
27. A Müller T Edmonston D Corao 2002 Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer Cancer Res 62 1014 9
28. HFA Vasen J Wijnen F Menko 1996 Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis Gastroenterology 110 1020 7
29. K Lin M Shashidharan A Thorson 1998 Cumulative incidence of colorectal and extracolonic cancer in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer J Gastrointest Surg 2 67 71
30. JA Baron BF Cole RS Sandler 2003 A randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 891 9
31. RS Sandler S Halabi JA Baron 2003 A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer N Engl J Med 348 883 90
32. RK Phillips MH Wallace PM Lynch 2002 A randomized, double blind, placebo-controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis Gut 50 857 60
33. R Benamouzig J Deyra A Martin 2003 Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial Gastroenterology 125 328 36
34. Y Hendriks A Wagner H Morreau 2004 Cancer risk in hereditary non polyposis colorectal cancer due to MSH6 mutations; impact on counselling and surveillance Gastroenterology 127 1 17 25
35. J Kim C Hee A Seon 2001 hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer Cancer Detect Prev 25 503 10
36. Cappel de Vos tot Nederveen E Buskens Duijvendijk van 2003 Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect Gut 52 1752 5
37. S Syngal JC Weeks D Schrag 1998 Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations Ann Intern Med 129 787 96
38. PA Goldberg MV Madden C Harocopos 1998 In a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary nonpolyposis colorectal cancer Dis Colon Rectum 41 1250 5
39. HFA Vasen M van Ballegooijen E Buskens 1998 A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers Cancer 82 1632 7
40. S Ramsey L Clarke R Etzioni 2001 Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer Ann Intern Med 135 577 88